Antazoline hydrochloride manufacturers

Filters

Filters

Filters , active

Country of origin : Spain
None products found

antazoline hydrochloride

Capsules, hard liquid 25 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17633
In the 1950s, the pharmaceutical laboratory was established. Its first manufacturing facility for inhalation aerosols was established in the 1960s, making it one of the first companies to introduce such a product to the market. It was one of the first firms in the world to sell silver sulfadiazine as a pharmaceutical product in cream and aerosol form.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

About antazoline hydrochloride

Antazoline hydrochloride manufacturers mainly supply eye drop makers, such as the producers of Spersallerg, while Polfa Warszawa makes the injectable antazoline mesylate (Phenazolinum) in Poland. Antazoline is a first-generation antihistamine. As the hydrochloride, it is used in eye drops for allergic conjunctivitis, usually with a decongestant. As the mesylate injection, it is used in Poland for allergic emergencies and to restore normal rhythm in atrial fibrillation. Pharmaceutical companies can source antazoline eye drops, injection and API through out-licensing, supply or technology transfer.

Antazoline hydrochloride key facts

Property

Antazoline hydrochloride

INN

Antazoline (as hydrochloride; also mesylate and phosphate salts)

Chemical name

N-benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)aniline

Molecular formula / weight

C17H19N3 / 265.4 g/mol (base)

CAS number

2508-72-7 (hydrochloride)

ATC code

R06AX05

Drug class

H1 antihistamine (ethylenediamine type); antiarrhythmic effect (injection)

Eye drop brand

Spersallerg: antazoline hydrochloride 0.5 mg/ml + tetryzoline hydrochloride 0.4 mg/ml

Eye drop markets

Switzerland, Poland, Czech Republic, Slovakia, Romania, Bulgaria, South Africa, Taiwan, Hong Kong and others

Injection brand

Phenazolinum (antazoline mesylate) 50 mg/ml, Polfa Warszawa, Poland

Indications (eye drops)

Allergic conjunctivitis and eye irritation with redness

Indications (injection)

Acute allergic conditions with adrenaline; paroxysmal supraventricular arrhythmias, including atrial fibrillation

Historical products

Antistin-Privin (with naphazoline); Vasocon-A (US, with naphazoline)

Patent status

Off-patent

Antazoline hydrochloride manufacturers and licensing history

Antazoline is an old antihistamine, originally sold as Antistin. It became widely used in eye drops combined with a decongestant, such as naphazoline (Antistin-Privin) or tetryzoline (Spersallerg). Spersallerg, with 0.5 mg/ml antazoline hydrochloride and 0.4 mg/ml tetryzoline, is registered in many countries in Europe, Asia, the Middle East and Africa.

In Poland, Polfa Warszawa makes Phenazolinum, an antazoline mesylate injection. Its antiarrhythmic effects were first described in the 1960s. It is now widely used in Polish emergency departments to restore normal rhythm in recent-onset atrial fibrillation, supported by registry studies (CANT) and a randomised trial against propafenone (AnProAF, 2024).

Antazoline API is produced by a small number of companies. Buyers should confirm the salt form (hydrochloride, mesylate or phosphate), GMP status and suitability for sterile eye drops or injection before choosing a supplier.

Antazoline hydrochloride dosage forms and dossier types

Antazoline is supplied as eye drops (hydrochloride, in combination) and as injection (mesylate). Most licensing interest is in combination eye drops.

Form

Strengths

Typical dossier

Notes

Antazoline / tetryzoline eye drops

0.5 mg/ml + 0.4 mg/ml

EU national dossier

Main form for licensing; reference Spersallerg

Antazoline / naphazoline eye drops

Per national MA

National dossier

Antistin-Privin type products

Antazoline mesylate injection

50 mg/ml (100 mg/2 ml)

Polish national dossier

Reference Phenazolinum

Antazoline API

Bulk

DMF

Hydrochloride, mesylate or phosphate

Target market

Dossier format

Key requirement

European Union

National dossier

Reference Spersallerg; sterile ophthalmic manufacturing

Poland

National dossier

Phenazolinum injection for arrhythmia and allergy

Asia, Middle East, Africa

National CTD

Spersallerg widely registered

Antazoline hydrochloride regulatory and patent status

Antazoline is off-patent. Antazoline and tetryzoline eye drops are authorised nationally in many countries, often without prescription. Phenazolinum injection is authorised in Poland for allergic emergencies and supraventricular arrhythmias. Antazoline is not included in major international atrial fibrillation guidelines, although Polish studies support its use for cardioversion.

Antazoline hydrochloride mechanism of action and therapeutic use

Antazoline blocks histamine H1 receptors, which reduces itching, redness and swelling in allergic conjunctivitis. In eye drops, it is combined with a decongestant that narrows blood vessels and reduces redness. Given intravenously, antazoline also has quinidine-like antiarrhythmic effects, which can restore normal rhythm in recent-onset atrial fibrillation.

Antazoline hydrochloride licensing and sourcing

Antazoline suppliers and licensing partners typically offer dossier out-licensing, finished-product supply or technology transfer. Buyers usually compare GMP status (EU GMP, WHO GMP), sterile manufacturing capability, salt form and territory availability. Current offers and supplier contacts are listed among the antazoline hydrochloride manufacturers on Pipelinepharma.

Frequently asked questions about antazoline hydrochloride

Who are the main antazoline manufacturers? Spersallerg eye drops, with antazoline hydrochloride and tetryzoline, are registered in many countries. Polfa Warszawa makes Phenazolinum injection (antazoline mesylate) in Poland.

What is antazoline hydrochloride used for? Antazoline hydrochloride is used in eye drops for allergic conjunctivitis, combined with a decongestant such as tetryzoline or naphazoline.

Is antazoline used for atrial fibrillation? Yes, in Poland. Antazoline mesylate injection (Phenazolinum) is used to restore normal rhythm in recent-onset atrial fibrillation.

What forms and strengths of antazoline are available? Antazoline is available as eye drops (0.5 mg/ml with 0.4 mg/ml tetryzoline in Spersallerg) and as a 50 mg/ml injection of antazoline mesylate.

Is an antazoline eye drop dossier available for licensing? Yes. Antazoline and tetryzoline eye drop dossiers can be licensed in national formats, referencing Spersallerg.

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.